Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued response to standard antiplatelet agents may expl...
Main Authors: | Jung Hwa Jung, Udaya S. Tantry, Paul A. Gurbel, Young-Hoon Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2015-04-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-95.pdf |
Similar Items
-
Novel approaches to P2Y12 inhibition and aspirin dosing
by: William A. E. Parker, et al.
Published: (2021-01-01) -
CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01) -
Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO Trial
by: Hyun-Woong Park, et al.
Published: (2021-06-01) -
Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
by: Georges Jourdi, et al.
Published: (2021-12-01) -
Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)